A previous study revealed that the survival benefit of ultramutated tumors with POLE mutations was profound compared with other subtypes of endometrial cancer.2 Interestingly, the co-occurrence of p190A and POLE mutations was observed in endometrial cancer (Fig. 1e). Here, POLE is linked to endometrial cancer.